Pier 88 Investment Partners »

Bridgebio Pharma shares owned by Pier 88 Investment Partners

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Pier 88 Investment Partners from 13F filings

Historical chart of Pier 88 Investment Partners investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Pier 88 Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Pier 88 Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $572k 7.7k 74.26

More positions owned by Pier 88 Investment Partners

Etsy Note 0.250% 6/1 (Principal)
Global Pmts Note 1.500% 3/0 (Principal)
Ppl Cap Fdg Note 2.875% 3/1 (Principal)
Nextera Energy Unit 11/01/2027 (NEE.PT)
Meritage Homes Corp Note 1.750% 5/1 (Principal)
Okta Note 0.375% 6/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv Convertible Preferred (HPE.PC)
Bank America Corp 7.25 Percentage Cnv Pfd L Convertible Preferred (BAC.PL)
Uber Technologies Note 0.875%12/0 (Principal)
Wells Fargo & Co Perp Pfd Cnv A Convertible Preferred (WFC.PL)
Shift4 Pmts Note 0.500% 8/0 (Principal)
Euronet Worldwide Note 0.750% 3/1 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Alliant Energy Corp Note 3.875% 3/1 Deleted (Principal)
Wec Energy Group Note 4.375% 6/0 (Principal)

View all positions for Pier 88 Investment Partners

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Geode Capital Management
Invesco
Susquehanna International

View all funds holding Bridgebio Pharma